Market Cap 107.01M
Revenue (ttm) 64.25M
Net Income (ttm) -61.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -96.26%
Debt to Equity Ratio -3.28
Volume 160,900
Avg Vol 702,070
Day's Range N/A - N/A
Shares Out 26.62M
Stochastic %K 8%
Beta 1.64
Analysts Sell
Price Target $7.50

Company Profile

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to...

Industry: Medical Devices
Sector: Healthcare
Phone: 661 367 9170
Fax: 661 749 9430
Address:
28159 Avenue Stanford, Suite 220, Valencia, United States
VALMS
VALMS Oct. 19 at 9:45 PM
$RCEL ONLY 15 million dollars in cash? New or revised lending covenants with ORBIMED?
1 · Reply
ja1234567
ja1234567 Oct. 18 at 12:26 PM
$RCEL this is actually great for the company. I heard nothing but bad things about the guy. Plus he is obviously bad on strategy. He he only question is whether it’s too late for them,
1 · Reply
JHR
JHR Oct. 17 at 5:16 PM
0 · Reply
alexpitti
alexpitti Oct. 17 at 3:36 PM
$RCEL JIM was a liar and a terrible people manager. The problem is it might take until the cms code in 2027 for the business to rebound. The november call won't be good because we will finally hear the truth.
1 · Reply
WorldShakerLuke
WorldShakerLuke Oct. 17 at 3:13 PM
$RCEL Have needed a CEO change for quite a while, so this is a good thing. Facts are they are THE game in town for wound treatment and it might take some time, but this is a long term buy and hold. I bought another 2500 shares, now holding 15k at $4.55
0 · Reply
JarvisFlow
JarvisFlow Oct. 17 at 3:07 PM
Lake Street has updated their rating for AVITA Medical ( $RCEL ) to Hold with a price target of 4.
0 · Reply
topstockalerts
topstockalerts Oct. 17 at 2:00 PM
Avita Medical Ltd's stock fell 21.9% pre-market on Friday following an immediate leadership change and board restructuring. The company named Cary Vance as interim CEO, replacing Jim Corbett, who also stepped down from the board. Vance will remain as Chairman and Jan Stern Reed was appointed Lead Independent Director. Avita plans to hire an executive search firm to find a permanent CEO, considering both internal and external candidates. BTIG analyst Ryan Zimmerman, who maintains a Sell rating and a $3.00 price target, commented that the leadership changes might bring temporary instability to the company. $RCEL
0 · Reply
Bruces4
Bruces4 Oct. 17 at 1:09 PM
$RCEL Short interest WAY DOWN past 30 days to 3.3M now. Lots covered on the God CANDLE on 19M shares the day of the European approval PR. Another big chunk will cover today with all the negative news behind us. Onward and upward from here - regardless the CHRONIC DESPERATE postings of the panicked shorts.
0 · Reply
healthcareguru
healthcareguru Oct. 17 at 12:58 PM
$RCEL don’t forget: they’re still out of cash!!!! PURE TRASH & NO CASH. $0 PT. 🐺👎
0 · Reply
UgoGreg
UgoGreg Oct. 17 at 12:48 PM
$RCEL https://youtu.be/DTJiFOQEvN4
0 · Reply
Latest News on RCEL
AVITA Medical Announces CEO Transition

Oct 16, 2025, 6:15 PM EDT - 8 days ago

AVITA Medical Announces CEO Transition


AVITA Medical: Reimbursement Reset And Breakeven Path By 2026

Sep 18, 2025, 7:30 AM EDT - 5 weeks ago

AVITA Medical: Reimbursement Reset And Breakeven Path By 2026


AVITA Medical Successfully Completes Australian Equity Raise

Aug 12, 2025, 8:30 AM EDT - 2 months ago

AVITA Medical Successfully Completes Australian Equity Raise


AVITA Medical to Host Investor Webinar Briefing

Aug 10, 2025, 7:00 PM EDT - 2 months ago

AVITA Medical to Host Investor Webinar Briefing


AVITA Medical, Inc. (RCEL) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 3:21 PM EDT - 2 months ago

AVITA Medical, Inc. (RCEL) Q2 2025 Earnings Call Transcript


AVITA Medical to Announce Second Quarter 2025 Financial Results

Jul 28, 2025, 4:05 PM EDT - 3 months ago

AVITA Medical to Announce Second Quarter 2025 Financial Results


AVITA Medical, Inc. (RCEL) Q1 2025 Earnings Call Transcript

May 8, 2025, 9:50 PM EDT - 6 months ago

AVITA Medical, Inc. (RCEL) Q1 2025 Earnings Call Transcript


AVITA Medical Reports First Quarter 2025 Financial Results

May 8, 2025, 4:03 PM EDT - 6 months ago

AVITA Medical Reports First Quarter 2025 Financial Results


AVITA Medical to Announce First Quarter 2025 Financial Results

Apr 17, 2025, 4:05 PM EDT - 6 months ago

AVITA Medical to Announce First Quarter 2025 Financial Results


After Sales Rebound In January, AVITA Is Set Up For A Monster Year

Feb 18, 2025, 12:01 PM EST - 8 months ago

After Sales Rebound In January, AVITA Is Set Up For A Monster Year


AVITA Medical, Inc. (RCEL) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 9:33 PM EST - 9 months ago

AVITA Medical, Inc. (RCEL) Q4 2024 Earnings Call Transcript


AVITA Medical's shares sink 19% after another forecast cut

Jan 7, 2025, 10:12 PM EST - 10 months ago

AVITA Medical's shares sink 19% after another forecast cut


AVITA Medical Just Tripled Its TAM In The Burn Market

Jan 2, 2025, 11:26 AM EST - 10 months ago

AVITA Medical Just Tripled Its TAM In The Burn Market


AVITA Medical, Inc. (RCEL) Q3 2024 Earnings Call Transcript

Nov 9, 2024, 6:39 AM EST - 1 year ago

AVITA Medical, Inc. (RCEL) Q3 2024 Earnings Call Transcript


AVITA Medical Reports Third Quarter Financial Results

Nov 7, 2024, 4:03 PM EST - 1 year ago

AVITA Medical Reports Third Quarter Financial Results


VALMS
VALMS Oct. 19 at 9:45 PM
$RCEL ONLY 15 million dollars in cash? New or revised lending covenants with ORBIMED?
1 · Reply
ja1234567
ja1234567 Oct. 18 at 12:26 PM
$RCEL this is actually great for the company. I heard nothing but bad things about the guy. Plus he is obviously bad on strategy. He he only question is whether it’s too late for them,
1 · Reply
JHR
JHR Oct. 17 at 5:16 PM
0 · Reply
alexpitti
alexpitti Oct. 17 at 3:36 PM
$RCEL JIM was a liar and a terrible people manager. The problem is it might take until the cms code in 2027 for the business to rebound. The november call won't be good because we will finally hear the truth.
1 · Reply
WorldShakerLuke
WorldShakerLuke Oct. 17 at 3:13 PM
$RCEL Have needed a CEO change for quite a while, so this is a good thing. Facts are they are THE game in town for wound treatment and it might take some time, but this is a long term buy and hold. I bought another 2500 shares, now holding 15k at $4.55
0 · Reply
JarvisFlow
JarvisFlow Oct. 17 at 3:07 PM
Lake Street has updated their rating for AVITA Medical ( $RCEL ) to Hold with a price target of 4.
0 · Reply
topstockalerts
topstockalerts Oct. 17 at 2:00 PM
Avita Medical Ltd's stock fell 21.9% pre-market on Friday following an immediate leadership change and board restructuring. The company named Cary Vance as interim CEO, replacing Jim Corbett, who also stepped down from the board. Vance will remain as Chairman and Jan Stern Reed was appointed Lead Independent Director. Avita plans to hire an executive search firm to find a permanent CEO, considering both internal and external candidates. BTIG analyst Ryan Zimmerman, who maintains a Sell rating and a $3.00 price target, commented that the leadership changes might bring temporary instability to the company. $RCEL
0 · Reply
Bruces4
Bruces4 Oct. 17 at 1:09 PM
$RCEL Short interest WAY DOWN past 30 days to 3.3M now. Lots covered on the God CANDLE on 19M shares the day of the European approval PR. Another big chunk will cover today with all the negative news behind us. Onward and upward from here - regardless the CHRONIC DESPERATE postings of the panicked shorts.
0 · Reply
healthcareguru
healthcareguru Oct. 17 at 12:58 PM
$RCEL don’t forget: they’re still out of cash!!!! PURE TRASH & NO CASH. $0 PT. 🐺👎
0 · Reply
UgoGreg
UgoGreg Oct. 17 at 12:48 PM
$RCEL https://youtu.be/DTJiFOQEvN4
0 · Reply
healthcareguru
healthcareguru Oct. 17 at 12:47 PM
$RCEL and the downgrades begin…still have to annihilate guidance and bankruptcy pending. Delisting in clear focus. Any fake bull here clearly can’t read or do math. GAME OVER. It’s a ZERO. 🐺👎
0 · Reply
healthcareguru
healthcareguru Oct. 17 at 12:45 PM
$RCEL EPIC DISASTER…see you at $0. I warned you. 🐺👎
0 · Reply
OpenOutcrier
OpenOutcrier Oct. 17 at 12:17 PM
$RCEL (-24.5% pre) AVITA Medical Announces CEO Transition https://ooc.bz/l/80978
0 · Reply
JarvisFlow
JarvisFlow Oct. 17 at 11:42 AM
D. Boral Capital updates rating for AVITA Medical ( $RCEL ) to Buy, target set at 14.
1 · Reply
Arcides
Arcides Oct. 17 at 10:52 AM
$RCEL that 3.6 low is waiting for this...
1 · Reply
healthcareguru
healthcareguru Oct. 17 at 1:40 AM
$RCEL WHAT DID I SAY?!?!? CEO = shitcanned; 3Q sales preannounced ~30% BELOW Street estimates; 2025 guidance getting slashed. BANKRUPTCY is IMMINENT. Proof they are further violating debt covenants. This will be down 75%+ FAST… $0 PT. 😂😂😂😂😂😂😂😂😂😂😂😂🐺🐺🐺🐺🐺👎👎👎👎👎 $XBI $IWM $IHI
0 · Reply
BioGem
BioGem Oct. 17 at 1:12 AM
$RCEL This news confirms that this company is a fiasco, revenue projection for Q3 is horrible, cash will evaporate, while large debt covenants again broken. This should be quite shortable at the open tomorrow.
1 · Reply
Wats_Up
Wats_Up Oct. 16 at 11:20 PM
$RCEL Kind of surprised by the afterhours drop. This sure sounds like good news to me.
0 · Reply
Wats_Up
Wats_Up Oct. 16 at 11:15 PM
$RCEL The Company expects preliminary revenue for the third quarter ended September 30, 2025, to be approximately $17 million. No wonder there has been a change.
0 · Reply
Wats_Up
Wats_Up Oct. 16 at 11:12 PM
0 · Reply
Wats_Up
Wats_Up Oct. 16 at 11:11 PM
$RCEL Wow! AVITA Medical", or the "Company"), a leading therapeutic acute wound care company, today announced that the Board of Directors has named Chairman of the Board Cary Vance as Interim Chief Executive Officer, effective immediately. In conjunction with this appointment, Jim Corbett is leaving his positions as CEO and member of the Board. Mr. Vance will continue to serve as Chairman of the Board, while Board member Jan Stern Reed has been appointed Lead Independent Director. The Board intends to engage an executive search firm to assist with selecting a permanent CEO. This process will include a mix of internal and external candidates, including Mr. Vance.
0 · Reply
Fmello
Fmello Oct. 10 at 9:18 PM
$RCEL https://spectrumnews1.com/oh/columbus/news/2025/08/11/advanced-technology-decreases-recovery-time-for-burn-survivors
0 · Reply